Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00490 | Boc-Phe-(Alloc)Lys-PAB-PNP | 1160844-44-9 |
| Boc-Phe-(Alloc)Lys-PAB-PNP is a complex biomedical compound being investigated as an innovative treatment for a variety of diseases, especially cancer. Known for its powerful properties, it effectively halts tumor progression through targeted neutralization of unique enzymes and pathways. | Inquiry | |
| BADC-00491 | Cbz-Phe-(Alloc)Lys-PAB-PNP | 159857-90-6 |
| Cbz-Phe-(Alloc)Lys-PAB-PNP is an important biomedical chemical product that has emerged as a potential therapeutic agent against various diseases. It has demonstrated outstanding capabilities as a candidate compound for targeted therapy against various malignancies, including breast and prostate cancer. This revolutionary compound, Cbz-Phe-(Alloc)Lys-PAB-PNP, utilizes its unique molecular structure to produce profound inhibitory effects on the proliferation of malignant cells. | Inquiry | |
| BADC-00492 | Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNP | 253863-34-2 |
| Inquiry | ||
| BADC-00493 | Fmoc-Ala-Ala-Asn-PAB-PNP | 1834516-06-1 |
| Fmoc-Ala-Ala-Asn-PAB-PNP is an excellent and highly discriminating inhibitor widely used in biomedicine for multiple purposes. It is widely used in the field of drug development, especially in the targeted detection and attenuation of malignancies and cancers. | Inquiry | |
| BADC-00494 | Ala-Ala-Asn-PAB | 2149584-00-7 |
| Ala-Ala-Asn-PAB is a peptide derivative widely used in biomedical fields. The product is known for its superior chemical properties, which are highly advantageous in targeted drug delivery and enhanced therapeutic efficacy. Its broad applications include drug research for a variety of diseases, especially cancer. | Inquiry | |
| BADC-00495 | Fmoc-Phe-Lys(Trt)-PAB-PNP | 1116086-09-9 |
| Inquiry | ||
| BADC-00496 | succimimidyl-4-azidobutyrate | 943858-70-6 |
| Succimimidyl-4-azidobutyrate is a superior biopharmaceutical formulation that can facilitate breakthrough drug development and research efforts. As a chemically mediated linker, it accelerates the synthesis of targeted drugs, ultimately resulting in good precision in drug delivery and modulated drug release. | Inquiry | |
| BADC-00497 | sulfo-LC-SPDP | 150244-18-1 |
| Inquiry | ||
| BADC-00499 | Mal-PEG6-NHS ester | 1599472-25-9 |
| Mal-PEG6-NHS ester is a non-cleavable ADC linker containing the Maleimide group, 6-unit PEG, and NHS ester. | Inquiry | |
| BADC-00502 | ATFB-SE | 126695-58-7 |
| ATFB-SE is an ADC non-cleavable linker with breakthrough potential in the field of drug release carriers and targeted therapy. It can be used for biomolecule, protein and peptide labeling. | Inquiry | |
| BADC-00503 | N-Succinimidyl 4-(N-maleimidomethyl) trans-cyclohexane 1-carboxylate | 71875-81-5 |
| N-Succinimidyl 4-(N-maleimidomethyl) trans-cyclohexane 1-carboxylate is an essential compound in the biomedical sector that exhibits high complexity and variability in its applications. Acting as a reactive linker, it facilitates the conjugation of biomolecules to proteins, peptides, or drugs, thereby enabling targeted therapeutic delivery for addressing diverse ailments including cancer and autoimmune disorders. Embracing this compound empowers the biomedical industry to explore innovative means of combating diseases. | Inquiry | |
| BADC-00504 | 5-Maleimidovalericacid-NHS | 103750-03-4 |
| 5-Maleimidovalericacid-NHS is a widely used bioconjugation reagent in the biomedical field, which can modify molecules such as proteins and peptides by establishing long-lasting amide bonds. This facilitates the creation of targeted medication management and diagnostic tools. | Inquiry | |
| BADC-00505 | 6-Maleimidocaproic acid sulfo-NHS | 103848-61-9 |
| 6-Maleimidocaproic acid sulfo-NHS is a small molecule reagent used in the biomedical industry. It is commonly used to modify biomolecules, such as proteins and antibodies, for site-specific conjugation. This compound enables the efficient and stable attachment of drugs, tags, or targeting moieties to these biomolecules, thereby facilitating the development of innovative treatments for a variety of diseases, including cancer and autoimmune diseases. | Inquiry | |
| BADC-00506 | GMBS | 80307-12-6 |
| GMBS is a non-cleavable linker widely used in antibody-drug conjugation development. Its unparalleled efficacy stems from its chemical cross-linking ability, promoting the covalent binding of proteins, peptides, antibodies and countless other molecules. Notably, GMBS occupies a key position in the fields of drug delivery systems, diagnostics, and evolving bioconjugation technologies. | Inquiry | |
| BADC-00507 | N-Hydroxysuccinimidyl-4-azidobenzoate | 53053-08-0 |
| N-Hydroxysuccinimidyl-4-azidobenzoate is a non-cleavable linker in the field of antibody drug conjugation and has been widely used in the field of bioconjugation and cross-linking. Its key role is to facilitate the development of targeted drug delivery systems and diagnostic tools of paramount importance. By creating covalent bonds between biomolecules and multiple agents or interfaces, it provides a way to precisely target and manage diseases such as cancer, autoimmune abnormalities, and infectious diseases. | Inquiry | |
| BADC-00508 | SPDPH | 158913-22-5 |
| SPDPH is a biochemical product used in cancer drug development. It acts as a linker moiety for attaching biomolecules to surfaces or to each other. The product plays a key role in drug delivery systems, cancer diagnostics and targeted therapies. SPDPH enables the targeted delivery of drugs and diagnostics, thereby increasing the efficacy and specificity of cancer treatments. | Inquiry | |
| BADC-00509 | MTS-4-NHS | 690632-55-4 |
| Inquiry | ||
| BADC-00512 | m-PEG1-NHS ester | 1027371-75-0 |
| m-PEG1-NHS ester is a PEG derivative containing an NHS ester. The NHS ester can be used to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. The hydrophilic PEG spacer increases solubility in aqueous media. m-PEG1-NHS ester is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00513 | (2S,2'S)-Bis(2,5-Dioxopyrrolidin-1-yl) 4,4'-Disulfanediylbis(2-Acetamidobutanoate) | 102814-00-6 |
| (2S, 2'S)-Bis(2, 5-dioxopyrrolidin-1-yl)4, 4'-disulfanediylbis(2-acetamidobutanoate) is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00514 | 2-(2-(2-(3-((2,5-Dioxopyrrolidin-1-yl)oxy)-3-Oxopropoxy)ethoxy)ethoxy)ethyl Acrylate | 1042435-35-7 |
| 2-(2-(2-(3-((2, 5-Dioxopyrrolidin-1-yl)oxy)-3-oxopropoxy)ethoxy)ethoxy)ethyl acrylate is a PEG linker for antibody-drug-conjugation (ADC). | Inquiry |
